External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis
2022 · Clinical and Experimental Medicine · 38 citations
https://doi.org/10.1007/s10238-022-00972-4
Y
Yunwei Han
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
411
Citations
10
h-index
11
i10-index
Yunwei Han is an academic researcher from Affiliated Hospital of Southwest Medical University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Lung Cancer Research Studies & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 10, co-authored 21 publications.
ORCID: 0000-0001-8330-0444Papers by this author
worksClinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis
2022 · Annals of Hepatology · 17 citations
https://doi.org/10.1016/j.aohep.2022.100710
A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma
2023 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-023-34135-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat